Background: The QT dispersion (QTd) can be used as effective reperfusion marker among cases who undergo primary Percutaneous Coronary Intervention (PCI) after having acute myocardial infarction. Objective: Study of the correlation between myocardial perfusion and QT dispersion on 12 lead surface ECG among patients who had acute ST-elevation myocardial infarction (STEMI) managed by primary PCI. Patients and methods: In a prospective cohort study, 100 cases admitted to the Cardiology Departments of Zagazig University Hospital and El-Zaitoun Specialized Hospital within 12 hours of symptom onset were recruited. This study included all patients who fulfilled the criteria for acute STEMI and were candidates for primary PCI. All cases underwent electrocardiogram (ECG), echocardiogram (ECHO), and coronary angiogram. Results: Myocardial electrical heterogeneity was rapidly restored to normal after effective reperfusion, whereas insufficient tissue reperfusion (Myocardial blush grade (MBG) lower or equal to 2) even with Thrombolysis in Myocardial Infarction (TIMI) III flow, was not related to the resolution of the increased QTd. QTd and corrected QTD (QTcd) were significantly shortened following recanalization of the infarct-related artery among cases with successful tissue-level myocardial reperfusion (MBG3). The pre-procedural QTd is a significant predictor of the patients' MBG (i.e., The MBG improves with lower pre-procedural QTd values and worsens with higher QTd values.) Conclusion: Effective revascularization of myocardial tissue was determined by MBG related to normal electrical heterogeneity restoration with reduction of QTd in the jeopardized myocardium. The pre-procedural QTd is a significant predictor of the patients' MBG.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.